Amgen Inc. buy BMO Capital Markets
Start price
03.05.24
/
50%
€292.50
Target price
03.05.25
€329.44
Performance (%)
-1.00%
Price
17.05.24
€287.50
Summary
This prediction is currently active. With a performance of -1.00%, the BUY prediction for Amgen Inc. by BMO_Capital_Markets is down slightly. A total of €2.07 was paid as dividends for this prediction. This prediction currently runs until 03.05.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Amgen Inc. | -0.139% |
iShares Core DAX® | -0.383% |
iShares Nasdaq 100 | 1.248% |
iShares Nikkei 225® | 0.525% |
iShares S&P 500 | 0.640% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at BMO Capital Markets from $336.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat